Back
Brainstorm Cell Therapeutics Stock Price Chart
Sponsored
BCLI
Sponsored
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
10
BCLI
Brainstorm Cell Therapeutics
Last Price:
1.87
Seasonality Move:
2.27%
7 Day Trial
ALL ACCESS PASS
$
7
"If I Had To Start Again..." Expert Reveals #1 Investing Hack
In his latest free guide, Duffy reveals... click here to continue reading...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight buying pressure.
Brainstorm Cell Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.01 | Sell |
20-day SMA: | 2.15 | Sell |
50-day SMA: | 3.37 | Sell |
200-day SMA: | 5.57 | Sell |
8-day EMA: | 2.02 | Sell |
20-day EMA: | 2.31 | Sell |
50-day EMA: | 3.16 | Sell |
200-day EMA: | 6.42 | Sell |
Brainstorm Cell Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 31.81 | Sell |
Chaikin Money Flow: | -6175 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.84 - 3) | Sell |
Bollinger Bands (100): | (3.01 - 5.79) | Sell |
Brainstorm Cell Therapeutics Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Brainstorm Cell Therapeutics Stock
Is Brainstorm Cell Therapeutics Stock a Buy?
- Brainstorm Cell Therapeutics share price is 1.94 while BCLI 8-day simple moving average is 2.01, which is a Sell signal.
- The stock price of BCLI is 1.94 while Brainstorm Cell Therapeutics 20-day SMA is 2.15, which makes it a Sell.
- Brainstorm Cell Therapeutics 50-day simple moving average is 3.37 while BCLI share price is 1.94, making it a Sell technically.
- BCLI stock price is 1.94 and Brainstorm Cell Therapeutics 200-day simple moving average is 5.57, creating a Sell signal.
BCLI Technical Analysis vs Fundamental Analysis
Sell
10
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy or a Sell?
-
Brainstorm Cell Therapeutics stock is rated a Sell
The current Brainstorm Cell Therapeutics [BCLI] share price is $1.94. The Score for BCLI is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Brainstorm Cell Therapeutics Stock Info
Market Cap:
10.29M
Price in USD:
1.94
Share Volume:
74.1K
Brainstorm Cell Therapeutics 52-Week Range
52-Week High:
11.89
52-Week Low:
1.88
Sell
10
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Brainstorm Cell Therapeutics Share Price Forecast
-
What is the Brainstorm Cell Therapeutics stock price today?
The Brainstorm Cell Therapeutics stock price is 1.94 USD today. -
Will BCLI stock go up or go down?
Brainstorm Cell Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Brainstorm Cell Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Brainstorm Cell Therapeutics is overvalued.
Is Brainstorm Cell Therapeutics Stock a Buy?
- Brainstorm Cell Therapeutics share price is 1.94 while BCLI 8-day exponential moving average is 2.02, which is a Sell signal.
- The stock price of BCLI is 1.94 while Brainstorm Cell Therapeutics 20-day EMA is 2.31, which makes it a Sell.
- Brainstorm Cell Therapeutics 50-day exponential moving average is 3.16 while BCLI share price is 1.94, making it a Sell technically.
- BCLI stock price is 1.94 and Brainstorm Cell Therapeutics 200-day simple moving average is 6.42, creating a Sell signal.
Fundamental Analysis of Brainstorm Cell Therapeutics
Is Brainstorm Cell Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.79 per share, and an increase next year of $0.67 per share.
Technical Analysis of Brainstorm Cell Therapeutics
Should I short Brainstorm Cell Therapeutics stock?
- BCLI Moving Average Covergence Divergence (MACD) indicator is -0.4, suggesting Brainstorm Cell Therapeutics is a Sell
- Brainstorm Cell Therapeutics Relative Strength Index (RSI) is 31.81, which suggest Brainstorm Cell Therapeutics is oversold
- The Bollinger Bands (25) for Brainstorm Cell Therapeutics is (1.84 - 3), which suggest Brainstorm Cell Therapeutics is a Sell
- The Bollinger Bands (100) for Brainstorm Cell Therapeutics is (3.01 - 5.79), which suggest Brainstorm Cell Therapeutics is a Sell
* Brainstorm Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.